SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-063984
Filing Date
2013-02-19
Accepted
2013-02-19 07:04:38
Documents
3
Period of Report
2013-02-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d488855d8k.htm 8-K 16046
2 EX-99.1 d488855dex991.htm EX-99.1 61169
3 GRAPHIC g488855img01.jpg GRAPHIC 7274
  Complete submission text file 0001193125-13-063984.txt   88544
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 13621423
SIC: 2836 Biological Products, (No Diagnostic Substances)